Leveraging Small Activating RNA: From Concept to Phase II Clinical Trials

Time: 11:30 am
day: Focus Day


  • Exploring the development of RNA activation to target tumour associated macrophages
  • Harnessing the upregulation of transcription factors genes to the bone marrow
  • Outlining the administration of RNA activation drug in over 130 patients with advanced cancer
  • Showcasing safety profile and clinical outcomes